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Background: Children who have unhealthy lifestyles are predisposed to develop hypertension, dyslipidemia and
other complications. The epidemic of obesity is also affecting children with congenital heart disease. The aim of this
study is to estimate the prevalence of obesity and describe associated risk factors, including family history in
children with congenital heart disease.
Methods: A cross-sectional study with 316 children and adolescents with congenital heart disease seen in an
outpatient clinic of a reference hospital. Collected sociodemographic data included family history of chronic
disease, dietary habits, laboratory tests (total cholesterol, HDL and LDL/cholesterol, triglycerides, fasting glucose,
CRP, hematocrit and hemoglobin), and anthropometric assessment. Anthropometric data of the caregivers was
self-reported.
Results: The prevalence of excess weight was 26.9%. Altered levels of total cholesterol were observed in 46.9%,
of HDL in 32.7%, LDL in 23.6% and of triglycerides levels in 20.0%. A higher frequency of family history of
obesity (42.6%; p = 0.001), dyslipidemia (48.1%; p = <0.001), diabetes (47.4%; p = 0.002), hypertension (39.2%; p = 0.006)
and ischemic disease (43.7%; p = 0.023), as well as significantly higher values of triglycerides (p = 0.017), glycemia
(p = 0.004) and C-reactive protein (p = 0.002) were observed among patients with excess weight.
Conclusion: The presence of modifiable risk factors and the variables associated to excess weight in this
population was similar to that described in the literature for children without congenital disease. As these
children already present the risks associated to heart disease, it is particularly important to promote a healthy
lifestyle in this group.
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During the last three decades, there has been a consider-
able increase in the prevalence of obesity in children and
adolescents (4–18 year-old) worldwide [1-3]. Children
and adolescents with unhealthy lifestyles are predisposed
to develop hypertension, dyslipidemia and other compli-
cations [4]. These factors, as well as physical inactivity,* Correspondence: lupellanda@gmail.com
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unless otherwise stated.may track into adulthood [5] and increase the risk of
chronic diseases such as atherosclerosis [1].
The epidemic of obesity is also affecting children with
congenital heart disease (CHD). More than one quarter
of this population is already overweight [6,7]. Two main
causes have been described: physical activity restrictions
and interventions for weight gain in infancy, when many
lesions cause undernutrition [5]. These interventions
often include consumption of increased calories and
foods with high fat and sodium content [8,9]. Although
nutritional requirements and physical functional capacity
change as these children grow older and their heart le-
sions are successfully treated, the inappropriate dietaryl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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across childhood [10]. The family frequently influences
these unhealthy behaviors, both directly, restricting phys-
ical activity, for example, and indirectly, by setting an un-
healthy model. When parents are obese, as one example,
the risk of obesity in their children is increased [11-14].
Therefore, the objective of the present study was to es-
timate the prevalence of overweight, obesity and associ-
ated physical activity habits, passive smoking, glycemia
and lipids in children with congenital heart disease. We
also sought to investigate cardiovascular risk factors
present in children’s families.
Methods
We conducted a cross-sectional study of 316 patients with
congenital heart disease, aged between 2 and 18 years, and
receiving outpatient care at the Pediatric Cardiology Out-
patient Clinic of a referral hospital between September
2010 and March 2013. The study protocol was approved
by the Institutional Research Ethics Committee of Instituto
de Cardiologia do Rio Grande do Sul, Brazil (4470/2010).
Patients who had innocent murmur, clinical conditions
that prevented anthropometric assessment (wheelchair
users, malformation of the lower limbs, etc.), genetic
syndromes or children without a diagnosis of structural
heart disease were excluded from the study.
Data collection was performed according to a weekly
list of patients scheduled for routine outpatient visits.
Based on this list, the children’s guardians were con-
tacted by telephone, and the patients were invited to
participate in the study. Those who accepted to partici-
pate were asked to fast for 12 hours before laboratory
tests. Patients who could not be reached by phone were
invited to participate during the medical visit, and their
laboratory tests were scheduled for another day.
All patients and guardians received information about
the study and, after accepting to participate, signed the
written consent form. Next, patients underwent collec-
tion of blood samples and anthropometric assessment.
The participants’ caregivers present during data collec-
tion provided information about family risk factors and
physical activity habits (International Physical Activity
Questionnaire-IPAQ short version) [15]. Data were col-
lected using a questionnaire administered by health pro-
fessionals who attended two specific training sessions
and received training updates regularly. After being assessed,
participants who showed abnormal results were referred to
multidisciplinary outpatient care for prevention and treat-
ment of risk factors.
Weight was measured to the nearest 0.1 kg and height to
the nearest centimeter using a Welmy electronic digital
scale with stadiometer, with 200 Kg capacity, with the child
standing, without shoes or heavy clothing. Nutritional
status was based on body mass index (BMI), and classifiedusing the software WHO Anthro and Anthro Plus. Cutoff
points for underweight/normal weight (<85th percentile)
and excess weight (>85th percentile being overweight
85th −95th percentile and obesity > 95 percentile) for
BMI values were used according to the WHO-2006/
2007 [16].
Blood was collected by peripheral venous puncture
after 12 h fasting. The hematocrit and hemoglobin were
determined using whole blood collected with ethylenedi-
aminetetraacetic acid (EDTA), in an automated analyzer
(Coulter Act, Coulter, USA). Biochemical analysis of
total cholesterol, LDL, HDL cholesterol and triglycerides
were determined in serum obtained by centrifugation of
blood samples, through enzymatic method on an auto-
mated analyzer (Selectra E, Vital Scientific, USA), using
reagent kits and protocols according to instructions of
the manufacturer. Levels of hs-CRP were determined in
serum by nephelometry, using a Behring Nephelomefer
100 Analyzer (Dade Behring, USA).
Blood tests were considered abnormal according to
the U.S. pediatric guidelines (2011) and the I Brazilian
Guidelines for Prevention of Atherosclerosis in Childhood
and Adolescence (2005): total cholesterol > 170 mg/dL,
HDL/cholesterol < 45 mg/dL, LDL/cholesterol > 110 mg/dL,
triglycerides > 75 mg/dL (2–9 years) or > 90 mg/dL (10–18
years) [17], fasting glucose > 100 mg/dL, CRP > 0.30 mg/dL,
hematocrit < 35%, and hemoglobin < 11.0 g/dL [18].
Sample size was estimated as 250 children and adoles-
cents, based on the prevalence of obesity observed in a
previous study [19], with absolute error margins ranging
from 3% to 6% with a confidence level of 95%.
Data were stored and analyzed using the computer
program SPSS, version 17.0. The prevalence rates were
expressed as percentages with 95% confidence intervals.
The association between risk factors was assessed using
the chi-square test or Fisher’s exact test. Differences be-
tween the groups with and without risk factors were
evaluated using the Student t test or Mann–Whitney
test for continuous variables and the chi-square test or
Fisher’s exact test for categorical variables (gender, total
cholesterol, HDL/cholesterol, LDL/cholesterol, triglycer-
ides, hematocrit, hemoglobin, glucose, BMI percentile).
Poisson multiple logistic regression analysis was adjusted
for family history (obesity, dyslipidemia, diabetes, hyper-
tension, and ischemic heart disease), mother’s nutritional
status, both parents’ nutritional status, and adolescents’
age. Statistical significance was set at p-value ≤ 0.05.
This report is presented as suggested by the STROBE
statement: guidelines for reporting observational stud-
ies [20].
Results
A total of 341 patients were interviewed, but 25 did not
collect blood and were excluded from analysis, resulting
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Caucasian (81.6%) and aged between 6 and 11 years
(43.7%). The majority had been born at term (83.2%)
and had acyanotic congenital heart disease (81,1%). The
proportion of passive smoking was reported to be 43.7%
(Table 1).
Family history of cardiovascular risk factors included
excess weight in 44.3%, dyslipidemia in 53.8%, diabetes
in 49.7%, arterial hypertension in 83.2%, and ischemic
disease in 52.2% (Table 1).Table 1 General characteristics of the population




Preschool age (2–5 years) 67 (21.2)
School age (6–11 years) 138 (43.7)
Adolescents (12–18 years) 111 (35.1)
Born at term 263 (83.20)
Heart disease
Acyanotic
Ventricular Septal Defect (VSD) 76 (24.1)
Atrial Septal Defect (ASD) 61 (19.3)
Miscelaneous 119 (37,7)
Cyanotic
Tetralogy of Fallot 43 (13.6)
Pulmonary Atresia 6 (1.9)
Miscelaneous 11 (3,4)
Father’s educational level
Elementary school 191 (68.0)
High school 79 (28.1)
Incomplete/Complete higher education 11 (3.9)
Mother’s educational level
Elementary school 184 (60.7)
High school 94 (31.0)
Incomplete/Complete higher education 25 (8.3)
Number of siblings
Only child 67 (21.2)
Siblings 249 (78.8)
Positive family history for




Heart disease/ischemia 165 (52.2)
Presence of smokers in the household 138 (43.70)The prevalence of excess weight (BMI ≥ 85th percent-
ile) was 26.9%; of these, 17.4% were overweight (BMI >
P85 ≤ 95) and 9.5% were obese (BMI > P95). Excess weight
was more common among boys (60%). In the group of
6–11 years old, 34.1% presented with excess weight (p =
0.009). The group of acyanotic congenital heart disease
showed 27.7% of overweight, while in patients with cyan-
otic lesions the proportion was 23,3 (Table 2).
Regarding physical activity classification, children and
adolescents with excess weight were very active in 20%,
active in 36.5% and irregularly active in 40%, while eu-
trophic children were very active in 19.1%, active in
38.7% and irregularly active in 35.7% (p = 0.802).
There were 165 mothers (52,2%), and 92 fathers (29,1%)
with excess weight. Mothers’ and both parents’ excess
weight was significantly associated with children’s excess
weight (p = 0.003 and 0.049, respectively). The Prevalence
Ratio of an excess weight mother to have an excess weight
child was 1.24 (CI 1.08-1.43).
As shown in Table 3, the excess weight group had more
often a positive family history (first degree relative) for
obesity (p = 0.002), dyslipidemia (p = <0.001), diabetes
(p = 0.005), hypertension (p = 0.010), and ischemic dis-
ease (p = 0.040). The prevalence ratio for excess weight
in children was 1.92 (CI 1.22 ± 3.02, p = 0.005) when
the mother had excess weight and 1.74 (CI 1.15 ± 2.62;
p = 0.009) when there was a positive family history for
dyslipidemia.
Table 4 presents the laboratory tests results, showing
that 32.7% had low HDL, 18.4% had high total choles-
terol, 11.4% had high LDL, and 32.0% had increased triglyc-
erides. The excess weight group had significantly higher
triglycerides (p = 0.017), glucose (p = 0.004), and C-reactive
protein (p = 0.002).
Discussion
The present study reports a high prevalence of excess
weight in children and adolescents with congenital heart
disease. Aditionally, we observed a high frequency of ex-
cess weight in parents and a positive family history for
chronic non-transmissible diseases.
The prevalence of overweight and obesity in children
with congenital heart disease was similar to that de-
scribed in the literature for children with non-congenital
disease [19,21] In a population of patients with congeni-
tal heart disease in the U.S., researchers found a preva-
lence of more than 25% of obese and overweight children
[22]. However, in a study published six years ago, the
excess weight rate of a population of children and ado-
lescents in Belgium was 7.6% [11].
In Brazil, the high prevalence of excess weight in
children and adolescents in general has been a reason
for concern, because other associated risk factors for
ischemic heart disease, such as hypertension, glucose
Table 2 Distribution of general characteristics of the population according to the BMI classification of individuals with
congenital heart disease
Variables Total 316 (%) Underweight/Normal weight 231 (%) Excess weight 85 (%) PR CI (95%) p
Male 176 (55.7) 125 (54.1) 51 (60) 1,20 0.84-1.74 0.321
Only child 67 (21.2) 49 (21.2) 18 (21.2) 1.0 0.65-1.55 0,99
Preterm birth 49 (15.5) 31 (13.4) 18 (21.2) 1.53 1.01-2.32 0.046
Age
Preschool age (2–5 years) 67 (21.2) 57 (24.7) 10 (11.8) 1.0 - -
School age (6–11 years) 138 (43.7) 91 (39.4) 47 (55.3) 2.29 1.24-4.23 0.008
Adolescent (12–18 years) 111 (35.1) 83 (35.9) 28 (32.9) 1.71 0.89-3.27 0.104
Congenital heart disease
Cyanotic 60 (19) 46 (19,9) 14 (16,5) 0,84 0,51-1,37 0,48
Acyanotic 256 (81) 185 (80,1) 71 (83,5) 1,0 - -
PR: prevalence ratio; CI: confidence interval.
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emerged [7,23-27].
The presence of modifiable risk factors for ischemic
heart disease in this population, such as an abnormal lipid
profile (high total cholesterol/LDL/triglycerides, low
HDL) and excess weight may lead individuals with
congenital heart disease to have a combination of risks
that may persist into adulthood [4,28]. These modifi-
able risk factors have been well discussed in the litera-
ture about children without heart disease [2,21].
The presence of chronic diseases in families of patients
with congenital heart disease is an additional risk factor
for ischemic disease [7,22,28,29], similarly to what oc-
curs for healthy children/adolescents [23,30] and adults
in general [31,32]. The presence of obesity in mothers in
our study was directly related to their children’s excess
weight. This findings could represent both biological/
genetic characteristics and family lifestyles [14,33,34]. In
a study comparing three generations of families, there
was a strong significant relationship between the BMI of
mothers and children, thus suggesting the discussion of
inheritance of family patterns and lifestyle, as well as
family phenotypes [14]. In another study evaluating the
role of parents in the treatment of childhood obesity, theTable 3 Family history of obesity and chronic diseases accord
heart disease
Variables Total 316 (%) Underweight/N
weight 231 (%)
1st-degree relative with
obesity 68 (21.5) 39 (16.9)
dyslipidemia 52 (16.5) 27 (11.7)
diabetes 38 (12.0) 20 (8.6)
hypertension 74 (23.4) 45 (19.5)
heart disease/ischemic disease 32 (10.1) 18 (7.8)
PR: prevalence ratio; CI: confidence interval.authors found that distorted maternal perception leads
mothers to see their children’s excess weight as normal,
making it difficult for them to admit their children need
treatment [34].
In our study, approximately half of children and ado-
lescents were irregularly active or sedentary. In many
cases, physical activity may be limited by the parents
anxiety [35].
Passive smoking was detected in almost half of the
population studied, a rate much higher than in a survey
conducted over the past decade, in which more than
25% of children lived with at least one smoking parent.
Exposure to secondhand smoking in children causes
higher rates of pneumonia, ear infections, sudden infant
death syndrome, asthma, and other negative health effects
[36]. In addition, children’s airways are more vulnerable,
suffering dramatically with the effects of secondhand smok-
ing [37]. Children exposed to tobacco smoke at a young
age are more likely to become smokers and continue the
cycle of smoking in adulthood [38].
It is important to consider that factors present since
the children’s conception may contribute to “program-
ming” of disease in adult life [39,40]. The quality of the
mother’s nutrition during pregnancy may affect the fetaling to the BMI categories of individuals with congenital
ormal Excess weight 85 (%) PR CI (95%) P
29 (34.1) 1.26 1.07-1.49 0.002
25 (29.4) 1.25 1.08-1.45 <0.001
18 (21.2) 1.16 1.03-1.3 0.005
29 (34.1) 1.22 1.04-1.44 0.010
14 (16.5) 1.1 0.99-1.22 0.040
Table 4 Laboratory tests according to the BMI categories
of individuals with congenital heart disease
Variables Underweight/Normal




Cholesterol 148.1 ± 25.6 154 ± 32.2 0.106
HDL 50.3 ± 11.3 48.9 ± 12.2 0.352
LDL 83.3 ± 21.7 89.3 ± 27.8 0.053
Triglycerides 72.6 ± 34.3 83.7 ± 38.8 0.017
Glucose 87 ± 9.5 90.6 ± 9.0 0.004
C-reactive protein 0.1 ± 0.1 0.2 ± 0.2 0.002
Hematocrit 39.1 ± 4.1 38.8 ± 3.4 0.523
Hemoglobin 13.3 ± 1.9 12.9 ± 1.5 0.099
SD: standard deviation.
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food [41]. Along the life course, these factors interact
with family habits and childhood risks to compose dif-
ferent health and disease pathways [14].
The present study has some limitations that deserve to
be mentioned. Possible confounding biases may be re-
lated to memory bias and underreporting of information
by the respondents. Cross-sectional designs do not allow
causal inferences or detailed evaluation of sequences of
events. Despite these limitations, to the best at our
knowledge, this is one of the largest series of patients
with congenital heart disease evaluated for these risk in
Brazil or other developing countries.Conclusions
The obesity epidemic also affects children and adoles-
cents with congenital heart disease. In this population,
factors inherent to the heart disease can be added to
other traditional risk factors for the development of is-
chemic heart disease in the future. Changes in the life-
style are necessary to change these risk factors and its
comorbidities in the adult life of these people who are
living longer.
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